Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. / Ryskjaer, Jakob; Deacon, Carolyn F; Carr, Richard D; Krarup, Thure; Madsbad, Sten; Holst, Jens; Vilsbøll, Tina; Ryskjaer, Jakob; Deacon, Carolyn F.; Carr, Richard D; Krarup, Thure; Madsbad, Sten; Holst, Jens Juul; Vilsbøll, Tina.

In: European Journal of Endocrinology, Vol. 155, No. 3, 01.09.2006, p. 485-93.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ryskjaer, J, Deacon, CF, Carr, RD, Krarup, T, Madsbad, S, Holst, J, Vilsbøll, T, Ryskjaer, J, Deacon, CF, Carr, RD, Krarup, T, Madsbad, S, Holst, JJ & Vilsbøll, T 2006, 'Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake', European Journal of Endocrinology, vol. 155, no. 3, pp. 485-93. https://doi.org/10.1530/eje.1.02221, https://doi.org/10.1530/eje.1.02221

APA

Ryskjaer, J., Deacon, C. F., Carr, R. D., Krarup, T., Madsbad, S., Holst, J., ... Vilsbøll, T. (2006). Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. European Journal of Endocrinology, 155(3), 485-93. https://doi.org/10.1530/eje.1.02221, https://doi.org/10.1530/eje.1.02221

Vancouver

Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J et al. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. European Journal of Endocrinology. 2006 Sep 1;155(3):485-93. https://doi.org/10.1530/eje.1.02221, https://doi.org/10.1530/eje.1.02221

Author

Ryskjaer, Jakob ; Deacon, Carolyn F ; Carr, Richard D ; Krarup, Thure ; Madsbad, Sten ; Holst, Jens ; Vilsbøll, Tina ; Ryskjaer, Jakob ; Deacon, Carolyn F. ; Carr, Richard D ; Krarup, Thure ; Madsbad, Sten ; Holst, Jens Juul ; Vilsbøll, Tina. / Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. In: European Journal of Endocrinology. 2006 ; Vol. 155, No. 3. pp. 485-93.

Bibtex

@article{63d6eeb0ab4b11ddb5e9000ea68e967b,
title = "Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake",
abstract = "OBJECTIVE: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide are incretin hormones, secreted in response to meal ingestion. The incretin hormones stimulate insulin secretion and are essential for the maintenance of normal plasma glucose concentrations. Both incretin hormones are metabolized quickly by the enzyme dipeptidyl peptidase-IV (DPP-IV). It is well known that type-2 diabetic patients have an impaired incretin effect. Therefore, the aim of the present study was to investigate plasma DPP-IV activity in the fasting and the postprandial state in type-2 diabetic patients and control subjects. DESIGN: The study included two protocols. Protocol one involved 40 fasting type-2 diabetic patients (28 men); age 61 +/- 1.4 (mean +/- s.e.m.) years; body mass index (BMI) 31 +/- 0.6 kg/m(2); HbAlc 7.2 +/- 0.2{\%}; and 20 matched control subjects (14 men) were studied. Protocol two involved eight type-2 diabetic patients (six men); age 63 +/- 1.2 years; BMI 33 +/- 0.5 kg/m(2); HbAlc 7.5 +/- 0.4{\%}; eight matched control subjects were included. METHODS: In protocol one, fasting values of DPP-IV activity were evaluated and in protocol two, postprandial DPP-IV activity during a standard meal test (566 kcal) was estimated. RESULTS: Mean fasting plasma DPP-IV activity (expressed as degradation of GLP-1) was significantly higher in this patient group compared with the control subjects (67.5 +/- 1.9 vs 56.8 +/- 2.2 fmol GLP-1/h (mean +/- s.e.m.); P=0.001). In the type-2 diabetic patients, DPP-IV activity was positively correlated to FPG and HbAlc and negatively to the duration of diabetes and age of the patients. No postprandial changes were seen in plasma DPP-IV activity in any of the groups. CONCLUSIONS: Plasma DPP-IVactivity increases in the fasting state and is positively correlated to FPG and HbAlc levels, but plasma DPP-IV activity is not altered following meal ingestion and acute changes in plasma glucose.",
author = "Jakob Ryskjaer and Deacon, {Carolyn F} and Carr, {Richard D} and Thure Krarup and Sten Madsbad and Jens Holst and Tina Vilsb{\o}ll and Jakob Ryskjaer and Deacon, {Carolyn F.} and Carr, {Richard D} and Thure Krarup and Sten Madsbad and Holst, {Jens Juul} and Tina Vilsb{\o}ll",
note = "Keywords: Antigens, CD26; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Hemoglobin A, Glycosylated; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged",
year = "2006",
month = "9",
day = "1",
doi = "10.1530/eje.1.02221",
language = "English",
volume = "155",
pages = "485--93",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "3",

}

RIS

TY - JOUR

T1 - Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake

AU - Ryskjaer, Jakob

AU - Deacon, Carolyn F

AU - Carr, Richard D

AU - Krarup, Thure

AU - Madsbad, Sten

AU - Holst, Jens

AU - Vilsbøll, Tina

AU - Ryskjaer, Jakob

AU - Deacon, Carolyn F.

AU - Carr, Richard D

AU - Krarup, Thure

AU - Madsbad, Sten

AU - Holst, Jens Juul

AU - Vilsbøll, Tina

N1 - Keywords: Antigens, CD26; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Hemoglobin A, Glycosylated; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged

PY - 2006/9/1

Y1 - 2006/9/1

N2 - OBJECTIVE: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide are incretin hormones, secreted in response to meal ingestion. The incretin hormones stimulate insulin secretion and are essential for the maintenance of normal plasma glucose concentrations. Both incretin hormones are metabolized quickly by the enzyme dipeptidyl peptidase-IV (DPP-IV). It is well known that type-2 diabetic patients have an impaired incretin effect. Therefore, the aim of the present study was to investigate plasma DPP-IV activity in the fasting and the postprandial state in type-2 diabetic patients and control subjects. DESIGN: The study included two protocols. Protocol one involved 40 fasting type-2 diabetic patients (28 men); age 61 +/- 1.4 (mean +/- s.e.m.) years; body mass index (BMI) 31 +/- 0.6 kg/m(2); HbAlc 7.2 +/- 0.2%; and 20 matched control subjects (14 men) were studied. Protocol two involved eight type-2 diabetic patients (six men); age 63 +/- 1.2 years; BMI 33 +/- 0.5 kg/m(2); HbAlc 7.5 +/- 0.4%; eight matched control subjects were included. METHODS: In protocol one, fasting values of DPP-IV activity were evaluated and in protocol two, postprandial DPP-IV activity during a standard meal test (566 kcal) was estimated. RESULTS: Mean fasting plasma DPP-IV activity (expressed as degradation of GLP-1) was significantly higher in this patient group compared with the control subjects (67.5 +/- 1.9 vs 56.8 +/- 2.2 fmol GLP-1/h (mean +/- s.e.m.); P=0.001). In the type-2 diabetic patients, DPP-IV activity was positively correlated to FPG and HbAlc and negatively to the duration of diabetes and age of the patients. No postprandial changes were seen in plasma DPP-IV activity in any of the groups. CONCLUSIONS: Plasma DPP-IVactivity increases in the fasting state and is positively correlated to FPG and HbAlc levels, but plasma DPP-IV activity is not altered following meal ingestion and acute changes in plasma glucose.

AB - OBJECTIVE: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide are incretin hormones, secreted in response to meal ingestion. The incretin hormones stimulate insulin secretion and are essential for the maintenance of normal plasma glucose concentrations. Both incretin hormones are metabolized quickly by the enzyme dipeptidyl peptidase-IV (DPP-IV). It is well known that type-2 diabetic patients have an impaired incretin effect. Therefore, the aim of the present study was to investigate plasma DPP-IV activity in the fasting and the postprandial state in type-2 diabetic patients and control subjects. DESIGN: The study included two protocols. Protocol one involved 40 fasting type-2 diabetic patients (28 men); age 61 +/- 1.4 (mean +/- s.e.m.) years; body mass index (BMI) 31 +/- 0.6 kg/m(2); HbAlc 7.2 +/- 0.2%; and 20 matched control subjects (14 men) were studied. Protocol two involved eight type-2 diabetic patients (six men); age 63 +/- 1.2 years; BMI 33 +/- 0.5 kg/m(2); HbAlc 7.5 +/- 0.4%; eight matched control subjects were included. METHODS: In protocol one, fasting values of DPP-IV activity were evaluated and in protocol two, postprandial DPP-IV activity during a standard meal test (566 kcal) was estimated. RESULTS: Mean fasting plasma DPP-IV activity (expressed as degradation of GLP-1) was significantly higher in this patient group compared with the control subjects (67.5 +/- 1.9 vs 56.8 +/- 2.2 fmol GLP-1/h (mean +/- s.e.m.); P=0.001). In the type-2 diabetic patients, DPP-IV activity was positively correlated to FPG and HbAlc and negatively to the duration of diabetes and age of the patients. No postprandial changes were seen in plasma DPP-IV activity in any of the groups. CONCLUSIONS: Plasma DPP-IVactivity increases in the fasting state and is positively correlated to FPG and HbAlc levels, but plasma DPP-IV activity is not altered following meal ingestion and acute changes in plasma glucose.

U2 - 10.1530/eje.1.02221

DO - 10.1530/eje.1.02221

M3 - Journal article

C2 - 16914604

VL - 155

SP - 485

EP - 493

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 3

ER -

ID: 8417093